Skip to main content
HUMANA INC logo

HUMANA INC — Investor Relations & Filings

Ticker · HUM ISIN · US4448591028 LEI · 529900YLDW34GJAO4J06 US Financial and insurance activities
Open in API
Filings indexed 3,056 across all filing types
Latest filing 2024-10-02 Director's Dealing
Country US United States of America
Listing US HUM

About HUMANA INC

https://www.humana.com/

Humana Inc. is a health and well-being company offering a broad range of health insurance products and healthcare services. The company primarily focuses on providing Medicare plans, including Medicare Advantage and Prescription Drug Plans (Part D), to eligible individuals. Beyond its Medicare offerings, Humana provides other medical and specialty insurance products. The company operates through two main segments: Insurance, which encompasses its health plans, and CenterWell, which delivers healthcare services such as primary care, pharmacy operations, and in-home care. Humana is committed to a personalized and simplified whole-person healthcare approach, aiming to help its members achieve better health outcomes through integrated care and wellness solutions.

Recent filings

Filing Released Lang Actions
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2024-10-02 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2024-10-02 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated October 2, 2024. It provides a Regulation FD Disclosure about preliminary 2025 Medicare Advantage Star Ratings data and its impact on the company. The content is an update on operational and financial outlook implications rather than a full financial report or earnings release. The document is about a specific event disclosure and does not contain comprehensive financial statements or detailed financial analysis. It is not an earnings release, annual report, or interim report. It is a regulatory filing providing material information to investors as required by the SEC. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2024-10-02 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2024-09-30 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2024-09-04 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC by Humana Inc. It includes a Regulation FD Disclosure about reaffirming earnings guidance for FY 2024, with detailed non-GAAP and GAAP EPS figures. The document is dated September 3, 2024, and contains forward-looking statements and a signature from the principal accounting officer. It does not contain comprehensive financial statements or detailed analysis typical of an Annual or Interim Report. Instead, it is an update on earnings guidance and investor communication. Form 8-K filings with Regulation FD disclosures and earnings guidance reaffirmations are best classified as Regulatory Filings (RNS) because they are regulatory announcements that do not constitute full financial reports or earnings releases (which are typically separate press releases or earnings call transcripts). The document length (5344 characters) and content confirm it is a regulatory announcement rather than a full report or earnings release.
2024-09-03 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.